"...would another company want to sign up for a DIC deal?" I think a concern should be why LEO isn't all over ATRYN if it actually works in the PII DIC trial? Without DIC efficacy, which is already way behind schedule, the ultimate value of GTC is significantly less, imo.
Market Data 
Markets 
AI
